<DOC>
	<DOC>NCT00448227</DOC>
	<brief_summary>This study will evaluate the acceptability and safety of famciclovir in infants with herpes simplex infection</brief_summary>
	<brief_title>Pharmacokinetics, Acceptability and Safety of Famciclovir in Infants (1 Month to Less Than 12 Months) With Herpes Simplex Infection</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Herpes Simplex</mesh_term>
	<mesh_term>Famciclovir</mesh_term>
	<mesh_term>2-Aminopurine</mesh_term>
	<criteria>Male and female patients from 1 month up to 1 year of age with herpes simplex infection Patients with gestational age less than 32 weeks. Patients unable to swallow. Patients with history of malabsorption or previous gastrointestinal surgery. Other protocoldefined inclusion/exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>1 Year</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Infants, Herpes simplex infection</keyword>
</DOC>